Punteggio di affidabilità 8/100
Professor Andrew John Davies
👤 2 anni di esperienza
2,341+
Patients seen
2
Years in practice
13
Publications
1
Languages spoken
Informazioni
Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Andrew John Davies
Istruzione e formazione
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncologia
Carriera e incarichi
-
2024-09–2025-08 Junior consultant
Licenze e assicurazione
Licenze mediche
GB — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Oncologia
Assicurazione responsabilità professionale:
HDI Global · 4,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 485 |
| Annual physical exam | 99395 | 275 |
| Vaccination administration | 90471 | 1,859 |
| Minor procedure (skin) | 17110 | 596 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 6 · i10: 9
-
Validation of clinical scoring in Oncologia
DOI: 10.9397/euroclin.2026.0 · PMID: 38476587 · citato da 181
-
Long-term follow-up of Oncologia across GB
DOI: 10.4077/euroclin.2025.1 · PMID: 37640225 · citato da 175
-
Validation of clinical scoring in Oncologia
DOI: 10.3304/euroclin.2024.2 · PMID: 39009386 · citato da 25
-
Long-term follow-up of Oncologia across GB
DOI: 10.1966/euroclin.2023.3 · PMID: 39559839 · citato da 107
Conferenze su invito
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Southampton · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Oncologia — Southampton · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2025
- national college of family doctors — Member · Dal 2025
- European Union of Medical Specialists (UEMS) — Member · Dal 2025
Articoli di questo medico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · andrew.john.davies@euroclinics.example
Posizione
1 tagRecensioni dei pazienti
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.